TET2 mutations have been also identified in mature B-cell (2%) and T-cell (11.9%) lymphomas [212,213], in 33% of angioimmunoblastic T-cell lymphomas [212], in mantle cell lymphomas [214], and diffuse large B-cell lymphomas. The gene discussed is TET2; the disease is angioimmunoblastic T-cell lymphoma.